Development of a Photoactivated Respiratory Support Device

光敏呼吸支持装置的开发

• 批准号: 7346971
• 负责人: Richard J Gilbert
• 金额: $ 59.55万
• 依托单位: THORATEC, LLC
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-01 至 2009-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7346971
• 关键词: Accounting; Adhesions; Adult; Area; Artificial Respiration; Automobile Driving; Binding; Biocompatible; Biodegradation; Biological Assay; Biomedical Technology; Biomimetic Materials; Blood; Blood capillaries; Blood flow; Carbon Dioxide; Cardiovascular Diseases; Cells; Chemicals; Chemistry; Child; Chronic; Chronic lung disease; Clinical; Condition; Data; Death Rate; Development; Devices; Diffuse; Diffusion; Disease; Electric Conductivity; Electrolytes; Erythrocytes; Film; Gases; Generations; Goals; Healthcare; Hemoglobin; Human; Life; Light; Liquid substance; Lung; Lung Transplantation; Lung diseases; Malignant Neoplasms; Membrane; Metabolic; Metabolism; Microfluidics; Modeling; Morbidity - disease rate; Nature; Numbers; Oxygen; Patient Care; Patients; Photons; Photosynthesis; Physiological; Plants; Plasma; Production; Property; Purpose; Quality of life; Rate; Reaction; Relative (related person); Research; Research Personnel; Respiration; Respiratory Failure; Respiratory physiology; Secondary to; Staging; Stress; Sunlight; Surface; System; Technology; Testing; Translating; Variant; Viscosity; Water; Whole Blood; absorption; artificial lung; base; biomaterial compatibility; capillary; chemical reaction; design; experience; innovation; interest; metal oxide; mortality; network models; quantum; research study; respiratory; sample fixation; size; technology development; titanium dioxide

DESCRIPTION (provided by applicant): In nature, the photolytic conversion of light to energy is a common mechanism for driving chemical reactions. As an example, photosynthesis utilizes energy derived from sunlight to promote key metabolic processes in plants, while exchanging oxygen for carbon dioxide. The purpose of the proposed research is to apply these physical principals to create an artificial system, composed of durable biomimetic materials, designed to replicate normal respiratory function. Despite vast improvements across the spectrum of health care in the past 20 years, there have been few substantial improvements in the care of patients with end- stage lung disease. While the death rate for most major diseases has decreased significantly, the rate of death related to chronic lung disease has actually increased during this period. As a result there has long been interest in the development of technology to replace severely diseased lungs. Since the proposed technology generates oxygen directly from the water content of whole blood, it avoids the need for gas-to- liquid diffusion membranes, pressurized gas, and gas cylinders, while retaining the full benefit of the red blood cell's ability to rapidly capture and transport dissolved oxygen. Our preliminary data has demonstrated the capacity to carry out photocatalytic respiration in blood flowing through a microchannel system, which is structurally and functionally similar to pulmonary capillaries. The overall goal of this proposal is build on this preliminary experience in order to develop a microfluidic scale device capable of carrying out artificial respiration powered by photocatalysis. Accordingly, our Specific Aims include the following: Specific Aim 1: Develop a photolytically active 2D microfludic device. Specific Aim 2: Develop metal oxide thin films with enhanced dissolved oxygen flux from the photocatalyst and reduced by-product carbon dioxide. Specific Aim 3: Determine basic biocompatibility of the microfluidic capillary system and photoactive components. It is anticipated that the successful implementation of this device in the clinical arena will have significant impact on the morbidity, mortality, and quality of life for the large number of children and adults with respiratory failure, as well as establishing an innovative realm of biomedical technology.

描述（由申请人提供）：在自然界中，光解将光转化为能量是驱动化学反应的常见机制。例如，光合作用利用来自阳光的能量来促进植物的关键代谢过程，同时将氧气交换为二氧化碳。拟议研究的目的是应用这些物理原理来创建一个人工系统，由耐用的仿生材料组成，旨在复制正常的呼吸功能。尽管在过去的20年里，医疗保健领域取得了巨大的进步，但对终末期肺病患者的护理却几乎没有实质性的改善。虽然大多数主要疾病的死亡率显著下降，但在此期间，与慢性肺病有关的死亡率实际上有所上升。因此，长期以来人们一直对开发替代严重病变肺部的技术感兴趣。由于所提出的技术直接从全血的含水量中产生氧气，它避免了对气-液扩散膜、加压气体和气瓶的需要，同时保留了红细胞快速捕获和运输溶解氧的能力的全部好处。我们的初步数据已经证明了在通过微通道系统的血液中进行光催化呼吸的能力，该系统在结构和功能上类似于肺毛细血管。本提案的总体目标是建立在这一初步经验的基础上，以开发一种能够进行由光催化驱动的人工呼吸的微流体规模装置。因此，我们的具体目标包括以下内容：具体目标1：开发光解活性二维微流体装置。具体目标2：利用光催化剂增强溶解氧通量，减少副产物二氧化碳，开发金属氧化物薄膜。专项目标3：确定微流控毛细管系统和光活性成分的基本生物相容性。预计该设备在临床领域的成功实施将对大量呼吸衰竭儿童和成人的发病率、死亡率和生活质量产生重大影响，并建立一个创新的生物医学技术领域。